Wegovy was also associated with a lower risk of hospitalization for heart failure, cardiovascular-related death, and ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Target has announced it will reduce bonuses for salaried employees due to weak consumer spending and inflationary pressures.

One doctor is losing her lunch over a bizarre ad in the window of a new pizza-bagel joint in Midtown that encourages people to take a popular weight-loss drug after wolfing down a meal there.

Novo Nordisk shares are experiencing a significant decline amidst intensified investor concerns over its competitiveness in ...

Lexicon Pharmaceuticals shares jumped nearly 75% in early trading Friday after the biopharmaceutical company inked a license agreement potentially worth $1 billion with Danish drug maker Novo Nordisk.

Lexicon's LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down ...

Pharma giant Novo Nordisk, which makes the obesity drug Wegovy, says the widespread availability of copycat medications is hurting its sales.

Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or ...

As more people lose weight using medications like Ozempic, Wegovy and Mounjaro, food companies ramp up their efforts to keep ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...